HUMIRA for Moderate to Severe Crohn’s Disease in Adults

HUMIRA for Moderate to Severe Crohn’s Disease in Adults

What is HUMIRA?

HUMIRA is a prescription medicine used to treat moderate to severe Crohn’s disease in adults and children 6 years of age and older.

HUMIRA Results for Adult Crohn’s Disease

In clinical studies at 4 weeks, many Crohn’s patients on HUMIRA achieved remission (few or no symptoms) and a majority saw symptom relief.

IN TWO CLINICAL STUDIES

PATIENTS ACHIEVED REMISSION AT 4 WEEKS

Taking HUMIRA®

Taking placebo

STUDY 1


36%
12%

STUDY 2


21%
7%

PATIENTS SAW SYMPTOM RELIEF AT 4 WEEKS

Taking HUMIRA®

Taking placebo

STUDY 1


58%
34%

STUDY 2


52%
34%

HUMIRA has helped many people notice a significant difference in their symptoms in as little as 4 weeks.

Individual results may vary.

Only you and your doctor can decide if HUMIRA is right for you. Patients who do not see results within 12 weeks should talk to their doctor.

Common side effects of HUMIRA

Common side effects of HUMIRA include injection site reactions (pain, redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all of the possible side effects with HUMIRA. Tell your doctor if you have any side effect that bothers you or that does not go away.

Read about the Important Safety Information for HUMIRA

CD Quick Poll

Are you currently using HUMIRA to treat your moderate to severe Crohn’s disease?

Visit HUMIRA Complete for access to potential savings, personalized support, and resources to help you stay on track with your prescribed treatment plan.

Learn About HUMIRA Complete

Explore another treatment option for adults with moderate to severe Crohn’s disease.

Learn more

HUMIRA® pen

HUMIRA Dosing for Adult Crohn’s Disease

Important: You must pay attention to your starting dose–it is different than your maintenance dose and is a critical part of taking HUMIRA as prescribed. Always follow your doctor’s instructions about when and how often to take HUMIRA.*

HUMIRA is given by injection under the skin.

Starting dose

Starting doses are higher doses to help you quickly reach an effective concentration of medicine in your body and they are typically administered on Day 1 and Day 15 of your treatment with HUMIRA. An initial Day 1 dose is 160 mg (given in one day or split over two consecutive days) followed by one 80 mg on Day 15.

Maintenance Dose

After that, you’ll continue with one 40 mg maintenance dose every other week starting on Day 29. This lower dose is meant to help you keep the amount of HUMIRA in your body at a stable level.

Your first dose of HUMIRA must be given under the supervision of a health care professional. Make sure you have been shown how to inject HUMIRA before you do it yourself. Remember to keep your HUMIRA refrigerated in its original container until ready for use.  

You should continue taking HUMIRA as directed by your doctor. Remember, HUMIRA is a treatment, not a cure. Your doctor can tell you if and when you should stop taking HUMIRA.

For more information, refer to the Patient Instructions for Use and the Medication Guide located inside the HUMIRA carton, and within the Full Prescribing Information. If you experience any adverse reactions or discomfort when taking HUMIRA, discuss them with your doctor right away.

*Refer to the Patient Instructions for Use to learn about the HUMIRA Pen and prefilled syringe.

Humira Complete

Start with support that’s designed around you

HUMIRA Complete gives you access to potential savings, injection training guides, and other helpful resources. Plus, you’re a phone call away from getting help with insurance coverage support.

How does HUMIRA work?

The protein TNF-alpha is believed to be part of your body’s natural processes involved in creating inflammation, and in some cases, excess inflammation. When used as prescribed, HUMIRA targets and blocks TNF-alpha, which can help reduce the excess inflammation associated with Crohn’s disease.

Discover another treatment option.

Explore a different treatment for adults with moderate to severe Crohn's disease.